Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer

Significant advancements have been made in recent years in advanced breast cancer and nearly all of them have been in the field of targeted therapy. Pertuzumab and trastuzumab-emtansine (T-DM1) have been able to be introduced in HER2-positive breast cancer. Now other anti-HER2 therapies are being de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Geburtshilfe Frauenheilkd
Main Authors: Welslau, Manfred, Hartkopf, Andreas D., Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Janni, Wolfgang, Ettl, Johannes, Lüftner, Diana, Belleville, Erik, Schütz, Florian, Fasching, Peter A., Kolberg, Hans-Christian, Nabieva, Naiba, Overkamp, Friedrich, Taran, Florin-Andrei, Brucker, Sara Y., Wallwiener, Markus, Tesch, Hans, Schneeweiss, Andreas, Fehm, Tanja N.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805215/
https://ncbi.nlm.nih.gov/pubmed/31656319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1001-9952
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados